NanoGhost  - pipeline header image .png

Pipeline

NanoGhost Therapeutic Pipeline

NanoGhost is developing a pipeline of encapsulated therapeutics for targeted delivery into multiple oncological indications

NanoGhost  - pipeline  image 2.png

Oncology

Candidate

Target Indication

Development Phase

Discovery

Preclinical

Phase I

Phase II

Phase III

NG-2001

mRNA, IL-12

Immune Oncology, Solid Tumors, TBD

NG-4001

Foreign Antigen TBD

Immune Oncology, Solid Tumors, TBD

Solid Tumors, TBD

NG-3001

DNA/Oncolytic Virus
(Collaboration with GeneMedicine)

NG-1001

Small Molecule, SN-38

Solid Tumors, TBD

NG-1002

Small Molecule, Olaparib

Solid Tumors, TBD